Valproic Acid (Valproic Acid (As Sodium Salt)) Patent Expiration, LOE Window & CMS Spending

Valproic Acid (Valproic Acid (As Sodium Salt)) by Pai Holding, Ll: Off-Patent Genericized (AB Competition), 0 AB generics, $17.1M 2024 CMS Part D & Medicaid spend, and 11 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPai Holding, Ll
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$17.1M
2024 Medicare Part D Spend$10.8M
2024 Medicaid Spend$6.3M
Reported Wholesale Price Change (CA SB 17)11 WAC filings (max 171.7% 2-yr change)